Skadden attorneys partner with life sciences and health care clients to address the most complex issues in transactional, litigation and enforcement, regulatory, finance, international arbitration, and intellectual property matters and to anticipate future issues that may arise throughout the industry. Companies and investors around the globe in every sector of the industry — including pharmaceutical, biotechnology and medical device companies; food and dietary supplement companies; hospital and health care systems and service providers; and long-term care facilities — rely on our sector-specific insights, timely and relevant legal advice, and all-encompassing collaboration to help them carve pathways through a quickly evolving landscape and to help realize scientific innovations.

  • We offer a full spectrum of transactional services to life sciences and health care companies, including advising on M&A, financings, corporate restructurings, and complex licensing and collaboration transactions. We handle critical matters of all sizes, from the largest mergers in the industry to transformative deals for smaller companies.
  • We provide compliance counseling on a range of intricate regulatory issues and help resolve disputes with the government or other parties before they blossom into more serious matters. Our attorneys have extensive experience with the Federal Food, Drug, and Cosmetic Act; the Public Health Service Act; the Civil Monetary Penalties Act; the Stark Law; the Anti-Kickback Statute; the Foreign Corrupt Practices Act; the Controlled Substances Act; and the False Claims Act.
  • We provide a comprehensive array of litigation and dispute resolution services, including representing clients in product liability defense; commercial, intellectual property and licensing disputes in litigation and arbitration (both domestic and international); internal investigations and government investigations and enforcement (civil and criminal); antitrust matters; and securities litigation.

The Skadden team was awarded the 2021 Healthcare, Pharma & Biotech Deal of the Year (Large Cap) by The Deal. In 2020, Skadden was named M&A Firm of the Year and received the award for Impact Deal of the Year by LMG Life Sciences, and in LMG Life Sciences’ 2019 rankings, Skadden was cited as a leading firm for both M&A and Products Liability within the life sciences industry. We were also recognized among the top firms for Health Care Law by U.S. News — Best Lawyers Best Law Firms 2020 and have been ranked as a leading firm for Healthcare in Chambers USA and for Life Sciences by The Legal 500 U.S.